Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit
cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at
opm.gov.
Gut Microbiome and Regulation on Immune Responses in Guillain-barre Syndrome: A Prospective Controlled Study
The following grant was awarded by, is supported by, is administered by or is in partnership with the Fogarty International Center at the U.S. National Institutes of Health (NIH).
Funding Fogarty Program
Global Brain Disorders Research
Project Information in NIH RePORTER
Gut Microbiome and Regulation on Immune Responses in Guillain-barre Syndrome: A Prospective Controlled Study
Principal Institution
International Centre for Diarrhoeal Disease Research, Bangladesh (ICDDR,B)
Principal Investigator(s) (PI)
Islam, Zhahirul
Project Contact Information
zislam@icddrb.org
Year(s) Awarded
2021–2023
Country
Bangladesh
Collaborators
Erasmus MC; University Medical Centre; the University of California; Johns Hopkins University; National Institute of Neurosciences & Hospital
Project Description
This research project will identify the Firmicutes rich species in gut microbiome in patients with Guillain-Barré syndrome (GBS) and determine the regulation of immune responses imposed by the host microbiome. The proposed study will provide new insight of gut-brain axis signaling to understand the role of gut microbiome through metagenomic approach and cellular expression of T and B cells repertoires, as well as correlate with clinical course and disease severity of GBS. The project will be a collaborative initiation between low- and middle-income countries (LMIC) and developed countries that enables to plan for mechanistic studies on gut microbiome regulation of immune responses for GBS patients to predict new therapeutic targets in future.
Related World Regions / Countries
Related Global Health Research Topics